メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 296 |
|---|
| ページあたり内部リンク平均 | 134.26 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| Update | 1 |
| Clinical | 0.651622 |
| Research | 0.628556 |
| Among | 0.102326 |
| Fees | 0.097674 |
| People | 0.095465 |
| Antiretroviral | 0.083721 |
| AAHIVS | 0.082451 |
| activity | 0.081322 |
| Sciences | 0.077787 |
| tenofovir | 0.074419 |
| award | 0.069767 |
| Therapy | 0.069767 |
| Outcomes | 0.069767 |
| Risk | 0.065116 |
| Consulting | 0.065116 |
| Viiv | 0.065116 |
| Treatment | 0.063432 |
| disclose | 0.063432 |
| Resistance | 0.060465 |
| Tenofovir | 0.060465 |
| Study | 0.060465 |
| PrEP | 0.057716 |
| Infection | 0.055814 |
| therapy | 0.055814 |
| among | 0.055814 |
| Care | 0.053194 |
| Annenberg | 0.051163 |
| interest | 0.050827 |
| University | 0.050827 |
| health | 0.050154 |
| Disease | 0.049501 |
| Women | 0.049016 |
| org | 0.048407 |
| Academy | 0.047654 |
| her | 0.046512 |
| Living | 0.046512 |
| Safety | 0.046512 |
| Men | 0.046512 |
| Eisenhower | 0.046512 |
| Healthcare | 0.046133 |
| Center | 0.046133 |
| care | 0.043587 |
| Health | 0.043501 |
| Conference | 0.042429 |
| Gilead | 0.042429 |
| HERE | 0.04186 |
| Long | 0.04186 |
| Use | 0.04186 |
| emtricitabine | 0.04186 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Research | Update | 5.242687 | 844 |
| Clinical | Research | 5.176474 | 852 |
| States | United | 3.831813 | 68 |
| Clinical | Update | 3.702253 | 645 |
| Click | HERE | 3.586649 | 43 |
| Consulting | Fees | 3.481408 | 57 |
| HERE | winner | 3.475049 | 36 |
| Healthcare | Viiv | 3.351028 | 50 |
| Click | winner | 3.323964 | 36 |
| Click | learn | 3.277466 | 41 |
| HERE | learn | 3.268367 | 38 |
| learn | winner | 3.165374 | 34 |
| Alafenamide | Tenofovir | 3.119026 | 34 |
| Annenberg | Center | 3.110395 | 44 |
| disoproxil | fumarate | 3.098194 | 28 |
| Directly | Received | 3.098194 | 28 |
| Commercial | Directly | 3.098194 | 28 |
| award | winner | 3.091905 | 35 |
| HERE | award | 3.071946 | 37 |
| Gilead | Sciences | 3.025333 | 48 |
| New | York | 3.005737 | 36 |
| AAHIVP | PharmD | 2.971443 | 39 |
| Click | award | 2.918959 | 37 |
| Received | Services | 2.883127 | 28 |
| managers | planners | 2.88208 | 24 |
| Nothing | disclose | 2.85748 | 41 |
| Eisenhower | Sciences | 2.842951 | 40 |
| award | learn | 2.828163 | 36 |
| Disoproxil | Fumarate | 2.815042 | 20 |
| antiretroviral | therapy | 2.807011 | 32 |
| Institute | Postgraduate | 2.741113 | 24 |
| Equity | Racial | 2.721293 | 20 |
| Antiretroviral | Therapy | 2.690987 | 40 |
| alafenamide | tenofovir | 2.687437 | 29 |
| Angeles | Los | 2.627416 | 16 |
| Review | Systematic | 2.627416 | 16 |
| Highlights | Part | 2.627416 | 16 |
| disoproxil | tenofovir | 2.622771 | 28 |
| Disoproxil | Tenofovir | 2.56382 | 22 |
| Commercial | Received | 2.553252 | 21 |
| Agents | their | 2.528704 | 28 |
| Efficacy | Safety | 2.520648 | 24 |
| CME | Services | 2.47385 | 28 |
| Commercial | interest | 2.441525 | 28 |
| assistants | physician | 2.440444 | 16 |
| Drugs | Inject | 2.440444 | 16 |
| Continuing | Education | 2.39378 | 18 |
| Collins | Ogle | 2.386972 | 12 |
| Hopkins | Johns | 2.386972 | 12 |
| Augusto | Caceres | 2.386972 | 12 |